Matthew B. Robers
Promega (United States)(US)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Histone Deacetylase Inhibitors Research, Epigenetics and DNA Methylation, Computational Drug Discovery Methods, Ubiquitin and proteasome pathways
Most-Cited Works
- → Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone Substrate(2012)1,666 cited
- → NanoBRET—A Novel BRET Platform for the Analysis of Protein–Protein Interactions(2015)485 cited
- → Quantitative Live-Cell Kinetic Degradation and Mechanistic Profiling of PROTAC Mode of Action(2018)307 cited
- → Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement(2017)281 cited
- → Target engagement and drug residence time can be observed in living cells with BRET(2015)281 cited
- → Application of BRET to monitor ligand binding to GPCRs(2015)256 cited
- → Potent and selective bivalent inhibitors of BET bromodomains(2016)134 cited
- → Selective JAK3 Inhibitors with a Covalent Reversible Binding Mode Targeting a New Induced Fit Binding Pocket(2016)127 cited
- → Discovery of a selective inhibitor of doublecortin like kinase 1(2020)113 cited
- → Quantifying CDK inhibitor selectivity in live cells(2020)109 cited